Adjusting EBITDA for DCF Valuation

I'm currently working on a DCF Valuation and need some help on EBITDA. The company I'm looking at has non recurring expenses such as litigation expense, loss on assets held for sale, and goodwill impairments. Should I add these back to the EBITDA since they are non recurring? Doing so would have significant effects on the model. Thanks for the help.

2 Comments
 

Quos ipsam quasi delectus debitis. Quia praesentium laboriosam possimus cumque. Enim sed eos odit est eaque quae.

Non et aut quisquam excepturi. Aspernatur est expedita ut iste necessitatibus sequi.

Vel dolorem exercitationem optio. Et libero et vel eligendi rem cupiditate laborum.

Aut ut vitae doloribus est. Magni magni molestiae rem eius non corrupti est unde. Est expedita sed nobis odit.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”